Wird geladen...
Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib
AIM: To identify clinical biomarkers that could early predict improved survival in patients with advanced-stage hepatocellular carcinoma (HCC) treated with transarterial chemoembolization combined with sorafenib (TACE-S). METHODS: We retrospectively evaluated the medical records of consecutive patie...
Gespeichert in:
| Veröffentlicht in: | World J Gastroenterol |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5787783/ https://ncbi.nlm.nih.gov/pubmed/29398869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v24.i4.484 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|